- Filed
- Mar 31, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 1.32M sh |
| Capex | FY 2024 · Dec 31, 2023 | $457K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$24.16M |
| Long Term Debt | FY 2024 · Dec 31, 2023 | $1.24M |
| Cash And Equivalents | FY 2024 · Dec 31, 2023 | $2.28M |
| Stockholders Equity | FY 2024 · Dec 31, 2023 | −$26.63M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $6.95M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $15.41M |
| Current Assets | FY 2024 · Dec 31, 2023 | $8.21M |
| Total Assets | FY 2024 · Dec 31, 2023 | $22.97M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$16.77 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$16.77 |
| Rd Expense | FY 2024 · Dec 31, 2023 | $6.35M |
| Net Income | FY 2024 · Dec 31, 2023 | −$22.12M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$26.29M |
| Gross Profit | FY 2024 · Dec 31, 2023 | −$2.02M |
| Cost Of Revenue | FY 2024 · Dec 31, 2023 | $14.82M |
| Revenue | FY 2024 · Dec 31, 2023 | $12.8M |